Sale!

PIGA Gene Early infantile epileptic encephalopathy type 20 Genetic Test

4,400 د.إ

-21%

The PIGA gene test for early infantile epileptic encephalopathy type 20 (EIEE20) is a specialized genetic examination designed to identify mutations in the PIGA gene, which are associated with this severe neurological condition. EIEE20 is characterized by early onset of frequent seizures, developmental delay, and various other neurological impairments. The test aims to provide a definitive diagnosis by analyzing the patient’s DNA for specific genetic abnormalities within the PIGA gene that are known to cause the disorder.

Conducted at DNA Labs UAE, a leading facility in genetic diagnostics, the test offers families and physicians critical information that can guide treatment decisions and prognosis. Understanding the genetic underpinnings of the condition can also be beneficial for genetic counseling, particularly for families considering future pregnancies.

The cost of the PIGA gene test for EIEE20 at DNA Labs UAE is 4400 AED. This price reflects the sophisticated technology and expertise required to accurately identify mutations in the PIGA gene. For families facing the challenges of EIEE20, this test represents a crucial step towards a clearer understanding of the condition and the potential for targeted therapeutic strategies.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

PIGA Gene Early Infantile Epileptic Encephalopathy Type 20 Genetic Test

Test Name: PIGA Gene Early Infantile Epileptic Encephalopathy Type 20 Genetic Test

Components: Blood or Extracted DNA or One drop Blood on FTA Card

Price: 4400.0 AED

Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card

Report Delivery: 3 to 4 Weeks

Method: NGS Technology

Test Type: Neurological Disorders

Doctor: Neurologist

Test Department: Genetics

Pre Test Information: Clinical History of Patient who is going for PIGA Gene Early Infantile Epileptic Encephalopathy Type 20 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with PIGA Gene Early Infantile Epileptic Encephalopathy Type 20.

Test Details

The PIGA gene is associated with Early Infantile Epileptic Encephalopathy Type 20 (EIEE20), a rare genetic disorder characterized by seizures that begin in the first months of life and developmental delays. The PIGA gene provides instructions for making a protein that is involved in the production of glycosylphosphatidylinositol (GPI) anchors, which attach proteins to the cell membrane.

Mutations in the PIGA gene can lead to a deficiency in GPI anchors, which can cause a range of symptoms including seizures, intellectual disability, and movement disorders. NGS genetic testing can be used to identify mutations in the PIGA gene that are associated with EIEE20. This type of testing uses next-generation sequencing technology to analyze a person’s DNA and identify any genetic variations that may be contributing to their symptoms.

This information can be used to make a diagnosis, guide treatment decisions, and provide information about the risk of passing the condition on to future generations.

Test Name PIGA Gene Early infantile epileptic encephalopathy type 20 Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card o
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Neurological Disorders
Doctor Neurologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for PIGA Gene Early infantile epileptic encephalopathy type 20 NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with PIGA Gene Early infantile epileptic encephalopathy type 20
Test Details

The PIGA gene is associated with Early Infantile Epileptic Encephalopathy Type 20 (EIEE20), a rare genetic disorder characterized by seizures that begin in the first months of life and developmental delays. The PIGA gene provides instructions for making a protein that is involved in the production of glycosylphosphatidylinositol (GPI) anchors, which attach proteins to the cell membrane. Mutations in the PIGA gene can lead to a deficiency in GPI anchors, which can cause a range of symptoms including seizures, intellectual disability, and movement disorders.

NGS genetic testing can be used to identify mutations in the PIGA gene that are associated with EIEE20. This type of testing uses next-generation sequencing technology to analyze a person’s DNA and identify any genetic variations that may be contributing to their symptoms. This information can be used to make a diagnosis, guide treatment decisions, and provide information about the risk of passing the condition on to future generations.